News

Derycz Scientific announced deal with Cubist Pharmaceuticals for medical literature access

The emergence of specialty pharmacies, with fundamental differences from other types of pharmacy providers, warrants the establishment of manufacturer relationships

Drug companies should keep a goal of effective communications as the priority in medical publications

FDA struggles with the new world of social media

‘Platform-as-a-Service’ (PaaS) offers IT efficiencies especially for emerging biopharma

Fifteen of top 25 are drug or device makers; hospitals and distributors round out the list

SDI Health extends its longitudinal patient analytics to measure media impacts

UPS gets ready to receive GS1 product-tracking data from anyone

As more temperature-sensitive product move around the globe, industry and regulators intensify their efforts to improve packaging and manage safe shipping

FDA denies use of ‘calendarizing’ features when added to an ANDA

GSK worked with Kenco Logistic Services for a coordinated launch

A potential savings of $46 billion in working capital is available to the industry, says Accenture study

Annual survey rank public companies by environmental, social criteria

Industry woes go beyond current global economic downturn

Pharma industry involvement in the supply-chain transaction service remains low

Annual compilation tracks evolution of wholesaler services, adoption of new technologies

Tried-and-true consumer-marketing techniques help product launches, patient adherence programs

‘Managed Market Delegates on Demand’ is one; ‘Ask IMS’ is another; meanwhile, online communities offer on-demand access

With sales of human pharmaceuticals languishing, several factors are focusing increased attention on animal health products, once a little-noticed industry niche market

Program seeks to improve the economics of care for low-income families; more sites to come

Usually associated with manufacturing or laboratory processes, quality systems can improve post-marketing compliance efforts

Nearly 30% of acquiring companies do not evaluate FCPA risks prior to an acquisition

While nurses move into a more central role in prescribing and administering pharmaceuticals, the nursing professions debate industry influence

TAKE Supply Chain helps Three Rivers Pharmaceuticals organize its distribution and shipping operations

New technologies are creating a powerful link between patients and healthcare providers. This Connected Health World has implications for pharmaceutical business practices

Aggressive cost competition and the continuing growth of generic substitution will separate retailers’ interests from manufacturers’

The desire to compare drugs’ efficacy is shifting from a purely medical decision to a financial one